Related Experiment Video

Updated: Jul 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

David S Stephens1, Brian Greenwood2, Petter Brandtzaeg3

  • 1Emory University School of Medicine, Atlanta, GA, USA; Research Service (151I), Atlanta VA Medical Center, Decatur, GA, USA.

Lancet (London, England)
|July 3, 2007
PubMed

Insights

Meningococcus causes devastating meningitis and sepsis globally. New vaccines targeting meningococcal serogroups offer hope for disease elimination, but equitable access in developing nations remains a challenge.

Area of Science:

  • Microbiology
  • Epidemiology
  • Vaccinology

Background:

  • Meningococcus is a major cause of epidemic meningitis and sepsis worldwide.
  • Significant progress has been made in understanding its biology, epidemiology, and pathogenesis.
  • Current diagnostic, treatment, and chemoprophylaxis strategies are based on recent scientific advances.

Purpose of the Study:

  • To review advances in meningococcal disease understanding and control.
  • To highlight the potential impact of next-generation vaccines.
  • To identify challenges in global vaccine implementation.

Main Methods:

  • Literature review of meningococcal biology, epidemiology, and clinical aspects.
  • Analysis of current and emerging diagnostic and therapeutic approaches.
  • Evaluation of vaccine development and implementation strategies.

Main Results:

  • Understanding of meningococcal pathogenesis and epidemiology has advanced significantly.
  • Next-generation conjugate vaccines for multiple serogroups and serogroup B are nearing availability.
  • Existing approaches for diagnosis, treatment, and chemoprophylaxis have been refined.

Conclusions:

  • New meningococcal vaccines hold promise for disease elimination in industrialized nations.
  • Equitable introduction of these vaccines in developing countries, particularly sub-Saharan Africa, is a critical challenge.
  • Continued research and strategic implementation are essential for global meningococcal disease control.

More Related Videos

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...